Breast Cancer Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- Women aged 18 or older.
- People who are generally well and able to carry out daily activities with little or no limitation (confirm with trial site).
- People with early breast cancer that has been confirmed by a tissue sample, and whose cancer falls into one of these two types: triple-negative breast cancer (a type that lacks certain hormone and protein receptors), or high-risk hormone receptor-positive, HER2-negative breast cancer (a type that responds to hormones but lacks a specific protein called HER2, and has certain higher-risk features).
- People whose cancer type and stage means that chemotherapy or other treatment before surgery is the recommended approach under standard medical practice.
- People who are able to understand the study information and sign a consent form approved by an ethics committee.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People whose cancer tests positive for a protein called HER2.
- People with cancer appearing in multiple spots in the breast, unless one main area can be clearly identified and sampled for testing.
- People who are known to have cancer that has spread to other parts of the body.
- People for whom the planned pre-surgery treatment would not be medically safe (confirm with trial site).
- People where the medical team has decided that surgery should happen first, before any other treatment.
- People who are unable to give informed consent.
- People who are pregnant or breastfeeding.
- People who have already received chemotherapy, immunotherapy, or hormone therapy for their current breast cancer before the initial biopsy for this study.
- People for whom a biopsy taken during treatment would not be safe or possible (confirm with trial site).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +390226437627
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
To characterize the dynamic changes in tumor and immune cell populations in TNBC and to prospectively collect serial samples from high-risk luminal (ER+/HER2-) breast cancer patients.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.